| Literature DB >> 35402506 |
Han Gao1, Chengwei He1, Rongxuan Hua2, Yuexin Guo3, Boya Wang4, Chen Liang2, Lei Gao5, Hongwei Shang6, Jing-Dong Xu1.
Abstract
The endoplasmic reticulum, a vast reticular membranous network from the nuclear envelope to the plasma membrane responsible for the synthesis, maturation, and trafficking of a wide range of proteins, is considerably sensitive to changes in its luminal homeostasis. The loss of ER luminal homeostasis leads to abnormalities referred to as endoplasmic reticulum (ER) stress. Thus, the cell activates an adaptive response known as the unfolded protein response (UPR), a mechanism to stabilize ER homeostasis under severe environmental conditions. ER stress has recently been postulated as a disease research breakthrough due to its significant role in multiple vital cellular functions. This has caused numerous reports that ER stress-induced cell dysfunction has been implicated as an essential contributor to the occurrence and development of many diseases, resulting in them targeting the relief of ER stress. This review aims to outline the multiple molecular mechanisms of ER stress that can elucidate ER as an expansive, membrane-enclosed organelle playing a crucial role in numerous cellular functions with evident changes of several cells encountering ER stress. Alongside, we mainly focused on the therapeutic potential of ER stress inhibition in gastrointestinal diseases such as inflammatory bowel disease (IBD) and colorectal cancer. To conclude, we reviewed advanced research and highlighted future treatment strategies of ER stress-associated conditions.Entities:
Keywords: cell death; colon cancer; endoplasmic reticulum stress; inflammatory bowel disease; treatment target; unfolded protein response
Year: 2022 PMID: 35402506 PMCID: PMC8988245 DOI: 10.3389/fmolb.2022.817392
Source DB: PubMed Journal: Front Mol Biosci ISSN: 2296-889X
FIGURE 1Model diagram of signaling pathways from three ER transmembrane stress sensors during UPR induced by ER stress. (A) IRE1α isolates from BiP undergo dimerization and phosphorylation to splice 26bp from XBP1 into XBP1s, which translocates to the nucleus and induces the transcription of target genes. (B) PERK signaling is initiated through PERK dimerization and autophosphorylation of the cytosolic PERK kinase domain. eIF2α phosphorylation is elicited to attenuate global protein synthesis. eIF2α promotes translation of ATF4, which translocates to the nucleus to regulate the expression of target genes and cooperates with CHOP to participate in ER stress-induced apoptosis pathways. (C) ATF6 dislocates from BiP translocates to Golgi apparatus, which is cleaved by proteases at S1P and S2P sites into ATF6f and promotes the transcription of genes.
FIGURE 2An illustration of MAMs and mitochondrial dysfunction in ER stress. MAMs are the ER membranes at the MERCs, which form a stable bridge between the ER membrane and the OMM, whose fusion is mediated by Mfn1, Mfn2, and Sig-1R. (A) Mfn2 is involved in alterations of mitochondrial morphology through binding to PERK and inhibiting PERK signaling. (B) As the local expression of chaperone proteins, Sig-1/BiP activates the IRE1/XBP1 signaling pathway via IRE1 dimerization. BI-1 resides on the MAMs and regulates mitochondrial Ca2+ concentration and apoptosis.
FIGURE 3Schematic diagram of apoptosis associated with the mitochondrial pathway and autophagy induced by ER stress. (A) Effector proteins of Bax and Bak in apoptosis undergo conformational changes in active forms and oligomerize in the ER membrane leading to the efflux of Ca2+ from the ER to the cytoplasm and activating m-calpain to cleave and activate procaspase-12, which in turn activates caspase-3 and caspase-7. BAX and BAK are associated with the decreased expression of IRE1 and XBP1 and promote apoptosis. Ca2+ can be taken up by mitochondria leading to depolarization of the mitochondrial inner membrane and cytochrome c release, which binds Apaf-1, procaspase-9, and ATP into apoptosome and activates caspase-9 and caspase-3, then resulting in cell death. (B) Dimmerized PERK phosphorylates the translation initiation factor eIF2α and mediates the translation of Atg12 and LC3. (C) Activated IRE1 forms P-IRE1α/TRAF2 complex and initiates Ask1 as a stress-responsive in the JNK and p38 pathways. Phosphorylated JNK along with activated P38 enters the nucleus to promote translation of AP1 and CHOP.
FIGURE 4Schematic highlights of the complex network on multiple factors involved in signaling pathways for ER stress-induced pyroptosis. Following injury, pro-inflammatory mediators of proIL-1β, NLRP3, and caspase-11 are increased transcription. ProIL-1β and TXNIP facilitate the assembly and activation of the NLRP3 inflammasome that cleaves procaspase-1 to active caspase-1, which in turn leads to process maturation of the IL-1β and initiating pyroptosis with the feature of plasma membrane rupture and DNA fragmentation along with multifarious cytopathological changes.
Small and large HSPs involved in diseases.
| 1 | S | Name | Disease | References |
|---|---|---|---|---|
| 2 | Small HSPs | HSP27 | Colorectal cancer; breast cancer; oral tongue squamous cell carcinoma |
|
| 3 | α-Crystallins | Tumors; neurodegenerative diseases; ocular diseases |
| |
| 4 | HSP70 | Lung cancer; acute myeloid; leukemia; colorectal cancer; gastric cancer |
| |
| 5 | HSP90 | Lung adenocarcinoma; esophageal squamous cell carcinoma; breast cancer |
| |
| 6 | Large HSPs | HSP110 | Brain ischemia, kainic acid-dependent cell injury, cerebellar Purkinje cell degeneration |
|
List of drugs inhibiting ER stress.
| 1 | Drug name | Mechanism of inhibition | References |
|---|---|---|---|
| 2 | 4-Phenylbutyric acid (4-PBA) | Suppressing oxidative stress by attenuating ER stress |
|
| 3 | Tauroursodeoxycholic acid (TUDCA) | Stabilizing unfolded proteins to prevent their aggregation from the induction of autophagy |
|
| 4 | Benzodiazepines | Selectively suppressing cell death associated with the IRE1 pathway though modulating phosphorylation of ASK1 and inhibiting downstream activation of JNK and p38 MAPK. |
|
| 5 | Baicalein | Attenuating pyroptosis, alleviating ER stress-mediated apoptosis to activate the autophagy process |
|
| 6 | 1-Deoxymannojirimycin | Inhibiting N-glycan processing in the ER to attenuate ER stress-induced cell death |
|
| 7 | Toyocamycin | IRE1 RNase inhibitors |
|
| 8 | 3-Ethoxy-5,6-dibromosa-licylaldehyde | A salicylaldehyde analog, IRE1 RNase inhibitors |
|
| A non-competitive inhibitor with respect to the XBP-1 RNA substrate | |||
| 9 | SFT-083010 | Aldehyde-based covalent as the inhibitors of the IRE1α′s RNase |
|
| 10 | MKC-3946 | Inhibiting IRE1α′s RNase |
|
| 11 | 4u8c | Inhibiting IRE1α′s RNase |
|
| 12 | GSK2606414 | Inhibiting PERK’s kinase |
|
| 13 | GSK2656157 | An ATP-competitive inhibitor of PERK enzyme |
|
| 14 | Geldanamycin | Inhibiting GRP 94 |
|
| Nonspecific HSP 90 inhibitor | |||
| 15 | 17-AAG (Phases I–III), SNX-5422 (Phase I), CNF 2024 (Phase II), and NVP-AUY922 (Phases I/II) | Specific HSP 90 inhibitor |
|
| 16 | Overexpression of BiP1 or BiP3 | Impede the accumulation of unfolded or misfolded proteins in the ER |
|